Cited by 153Neuroscience and Neuropharmacology ResearchNeuroinflammation and Neurodegeneration MechanismsChemokine receptors and signaling

Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity

Limatola, Cristina, Lauro, Clotilde, Catalano, Myriam, Ciotti, Maria Teresa, Bertollini, Cristina, Di Angelantonio, Silvia, Ragozzino, Davide, Eusebi, Fabrizio·2005·Journal of Neuroimmunology

Abstract

Excitotoxicity is a cell death caused by excessive exposure to glutamate (Glu), contributing to neuronal degeneration in many acute and chronic CNS diseases. We explored the role of fractalkine/CX3CL1 on survival of hippocampal neurons exposed to excitotoxic doses of Glu. We found that: CX3CL1 reduces excitotoxicity when co-applied with Glu, through the activation of the ERK1/2 and PI3K/Akt pathways, or administered up to 8 h after Glu insult; CX3CL1 reduces the Glu-activated whole-cell current through mechanisms dependent on intracellular Ca2+; CX3CL1 is released from hippocampal cells after excitotoxic insult, likely providing an endogenous protective mechanism against excitotoxic cell death.

Integrity signals

Registry

Crossref · 10.1016/j.jneuroim.2005.03.023

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Limatola, C., Lauro, C., Catalano, M., Ciotti, M. T., Bertollini, C., Di Angelantonio, S., Ragozzino, D., & Eusebi, F.
Affiliations
  • Istituto Pasteur (IT)
  • Institute of Neurobiology and Molecular Medicine (IT)
Venue
Journal of Neuroimmunology
Publisher
Elsevier BV
Published
2005-09
Volume
166
Issue
1-2
Pages
19-28
ISSN
0165-5728 (ISSN-L)
OpenAlex
W2032618901
Cited by
153
References
3
Citations by year
2026: 2 · 2025: 2 · 2024: 10 · 2023: 4 · 2022: 6 · 2021: 10 · 2020: 1 · 2019: 5 · 2018: 8 · 2017: 7 · 2016: 7 · 2015: 11 · 2014: 12 · 2013: 9 · 2012: 7
FWCI
1.93
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neuroimmunology (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
Keywords
fractalkine, excitotoxicity, glutamate, hippocampal neurons, neuroprotection, ERK signaling, PI3K/Akt signaling, intracellular calcium, excitatory postsynaptic currents
MeSH terms
Animals, Cell Survival, Cells, Cultured, Drug Administration Schedule, Drug Combinations, Electric Conductivity, Hippocampus, Membrane Proteins, Neurons, Neurotoxins, Rats, Wistar, alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid, Excitatory Amino Acid Agonists, Neuroprotective Agents, Glutamic Acid, Chemokines, CX3C, Rats, Chemokine CX3CL1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review